spacer
Topic quick links:
Cover page
spacer
All articles in this issue:
National Drugs Strategy Conference
Health Research Board welcomes new CEO
Supporting local efforts to tackle drug problems
Drug strategy to be evaluated
Dáil debate on cannabis
Homelessness Oversight Group submits its first report
Drug policy advocacy organisations in Europe
European research on risk factors for overdose
Preventing opiate-related deaths in Ireland: the naloxone demonstration project
Investigating the links between substance misuse and crime among young offenders
Problem-solving justice - establishing a community court in Dublin
Latest figures on drug-related deaths published
NDTRS drug treatment data for 2011 and 2012 available on line
Stakeholder consultation on Hidden Harm
Pharmacy needle exchange in Ireland
HSE services in 2014 - illicit drugs, smoking and alcohol misuse
Review of Dublin North City and County addiction service
Substance misuse in the eastern counties of HSE South
Ruhama annual report 2012
Inchicore Bluebell team launches strategy document
City Clinic marks 20 years in addiction services
Fifteenth annual Service of Commemoration and Hope
National Documentation Centre: new and updated resources
From Drugnet Europe
Recent publications
Upcoming events
Health Research Board welcomes new CEO
by HRB Communications Office

Dr Graham Love took over as chief executive of the Health Research Board (HRB) at the end of March. He replaces Enda Connolly, who retired on 31 January 2014 after more than five years in the position. 

Graham will bring 15 years’ leadership and senior management experience to the HRB, his most recent role being that of chief executive of Molecular Medicine Ireland. He previously held a number of senior positions at Science Foundation Ireland, where he was responsible for the development of SFI’s 2009–2013 strategy, Powering the Smart Economy, a €1.1 billion plan to drive delivery of the government’s enterprise science agenda, and its successor, Agenda 2020.

Graham was chief executive of Multiple Sclerosis Ireland between 2005 and 2006. Before that he spent almost a decade with management consulting firm Accenture. He graduated from University College Dublin with a BSc in Pharmacology in 1993, followed by a PhD in vascular cell biology in 1997.

 



Email Software by Newsweaver